| Role of MEKK1 in cell survival and activation of JNK and ERK pathways defined by targeted gene disruption T Yujiri, S Sather, GR Fanger, GL Johnson Science 282 (5395), 1911-1914, 1998 | 424 | 1998 |
| Molecular mimicry by Helicobacter pylori CagA protein may be involved in the pathogenesis of H. pylori‐associated chronic idiopathic thrombocytopenic purpura T Takahashi, T Yujiri, K Shinohara, Y Inoue, Y Sato, Y Fujii, M Okubo, ... British journal of haematology 124 (1), 91-96, 2004 | 408 | 2004 |
| MEK kinase 1 gene disruption alters cell migration and c-Jun NH2-terminal kinase regulation but does not cause a measurable defect in NF-κB activation T Yujiri, M Ware, C Widmann, R Oyer, D Russell, E Chan, Y Zaitsu, ... Proceedings of the National Academy of Sciences 97 (13), 7272-7277, 2000 | 293 | 2000 |
| Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults T Yasuda, S Tsuzuki, M Kawazu, F Hayakawa, S Kojima, T Ueno, N Imoto, ... Nature genetics 48 (5), 569-574, 2016 | 248 | 2016 |
| Anti-apoptotic versus pro-apoptotic signal transduction: checkpoints and stop signs along the road to death MB Jarpe, C Widmann, C Knall, TK Schlesinger, S Gibson, T Yujiri, ... Oncogene 17 (11), 1475-1482, 1998 | 220 | 1998 |
| MEKK1 regulates calpain-dependent proteolysis of focal adhesion proteins for rear-end detachment of migrating fibroblasts BD Cuevas, AN Abell, JA Witowsky, T Yujiri, NL Johnson, K Kesavan, ... The EMBO journal 22 (13), 3346-3355, 2003 | 178 | 2003 |
| MEKK1 suppresses oxidative stress-induced apoptosis of embryonic stem cell-derived cardiac myocytes T Minamino, T Yujiri, PJ Papst, ED Chan, GL Johnson, N Terada Proceedings of the National Academy of Sciences 96 (26), 15127-15132, 1999 | 161 | 1999 |
| CD5-positive diffuse large B-cell lymphoma: a retrospective study in 337 patients treated by chemotherapy with or without rituximab K Miyazaki, M Yamaguchi, R Suzuki, Y Kobayashi, AM Maeshima, ... Annals of Oncology 22 (7), 1601-1607, 2011 | 152 | 2011 |
| MEK kinase 1 (MEKK1) transduces c-Jun NH2-terminal kinase activation in response to changes in the microtubule cytoskeleton T Yujiri, GR Fanger, TP Garrington, TK Schlesinger, S Gibson, ... Journal of Biological Chemistry 274 (18), 12605-12610, 1999 | 152 | 1999 |
| Pre-transplant imatinib-based therapy improves the outcome of allogeneic hematopoietic stem cell transplantation for BCR–ABL-positive acute lymphoblastic leukemia S Mizuta, K Matsuo, F Yagasaki, T Yujiri, Y Hatta, Y Kimura, Y Ueda, ... Leukemia 25 (1), 41-47, 2011 | 146 | 2011 |
| MEKK1 is essential for cardiac hypertrophy and dysfunction induced by Gq T Minamino, T Yujiri, N Terada, GE Taffet, LH Michael, GL Johnson, ... Proceedings of the National Academy of Sciences 99 (6), 3866-3871, 2002 | 137 | 2002 |
| TRAF6 establishes innate immune responses by activating NF-κB and IRF7 upon sensing cytosolic viral RNA and DNA H Konno, T Yamamoto, K Yamazaki, J Gohda, T Akiyama, K Semba, ... PloS one 4 (5), e5674, 2009 | 132 | 2009 |
| Prospective monitoring of BCR‐ABL1 transcript levels in patients with Philadelphia chromosome‐positive acute lymphoblastic leukaemia undergoing imatinib … M Yanada, I Sugiura, J Takeuchi, H Akiyama, A Maruta, Y Ueda, N Usui, ... British journal of haematology 143 (4), 503-510, 2008 | 123 | 2008 |
| MEKK2 gene disruption causes loss of cytokine production in response to IgE and c-Kit ligand stimulation of ES cell-derived mast cells TP Garrington, T Ishizuka, PJ Papst, K Chayama, S Webb, T Yujiri, W Sun, ... The EMBO journal 19 (20), 5387-5395, 2000 | 123 | 2000 |
| Markedly improved outcomes and acceptable toxicity in adolescents and young adults with acute lymphoblastic leukemia following treatment with a pediatric protocol: a phase II … F Hayakawa, T Sakura, T Yujiri, E Kondo, K Fujimaki, O Sasaki, ... Blood cancer journal 4 (10), e252-e252, 2014 | 122 | 2014 |
| Endoplasmic reticulum stress induces Wfs1 gene expression in pancreatic β-cells via transcriptional activation K Ueda, J Kawano, K Takeda, T Yujiri, K Tanabe, T Anno, M Akiyama, ... European journal of endocrinology 153 (1), 167-176, 2005 | 93 | 2005 |
| Impact of MRD and TKI on allogeneic hematopoietic cell transplantation for Ph+ ALL: a study from the adult ALL WG of the JSHCT S Nishiwaki, K Imai, S Mizuta, H Kanamori, K Ohashi, T Fukuda, Y Onishi, ... Bone Marrow Transplantation 51 (1), 43-50, 2016 | 78 | 2016 |
| High-dose methotrexate therapy significantly improved survival of adult acute lymphoblastic leukemia: a phase III study by JALSG T Sakura, F Hayakawa, I Sugiura, T Murayama, K Imai, N Usui, ... Leukemia 32 (3), 626-632, 2018 | 66 | 2018 |
| Helicobacter pylori and chronic ITP: the discrepancy in the clinical responses to eradication therapy might be due to differences in the bacterial strains T Takahashi, T Yujiri, Y Tanizawa Blood 104 (2), 594-594, 2004 | 59 | 2004 |
| MEK kinase 1 mediates the antiapoptotic effect of the Bcr-Abl oncogene through NF-κB activation R Nawata, T Yujiri, Y Nakamura, K Ariyoshi, T Takahashi, Y Sato, Y Oka, ... Oncogene 22 (49), 7774-7780, 2003 | 54 | 2003 |
